Enliven Therapeutics, Inc. (ELVN)
38.83
+1.04
(+2.75%)
USD |
NASDAQ |
Apr 02, 16:00
38.72
-0.11
(-0.28%)
After-Hours: 20:00
Enliven Therapeutics Market Cap : 2.379B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Madrigal Pharmaceuticals, Inc. | 12.96B |
| Sarepta Therapeutics, Inc. | 2.556B |
| Coherus Oncology, Inc. | 257.07M |
| Kodiak Sciences, Inc. | 2.350B |
| Allogene Therapeutics, Inc. | 585.68M |
Market Cap Related Metrics
| Price to Book Value | 5.177 |
| Price | 38.83 |
| Earnings Yield | -4.67% |